Astria Therapeutics, Inc. Stock Forecast
Weaker technical forecast for Astria Therapeutics, Inc. as stock downgraded to Strong Sell Candidate.
(Updated on Apr 26, 2024)
The Astria Therapeutics, Inc. stock price fell by -1.85% on the last day (Friday, 26th Apr 2024) from $9.17 to $9.00. During the last trading day the stock fluctuated 5.46% from a day low at $8.97 to a day high of $9.46. The price has fallen in 6 of the last 10 days and is down by -16.74% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -211 thousand shares and in total, 1 million shares were bought and sold for approximately $9.89 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.87 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -21.70% during the next 3 months and, with a 90% probability hold a price between $6.94 and $11.66 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ATXS Signals & Forecast
There are mixed signals in the stock today. The Astria Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.56 and $12.58. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Astria Therapeutics, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.490 between high and low, or 5.46%. For the last week, the stock has had daily average volatility of 5.92%.
Astria Therapeutics, Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ATXS) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Astria Therapeutics, Inc. to open at $9.14, and during the day (based on 14 day Average True Range), to move between $8.19 and $9.81, which gives a possible trading interval of +/-$0.81 (+/-8.96%) up or down from last closing price. If Astria Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.93% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $9.17, some $0.170 (1.89%) from the current price of $9.00, our system finds the risk reward not very attractive.
Is Astria Therapeutics, Inc. stock A Buy?
Astria Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.
Current score: -5.188 Strong Sell Candidate Downgraded
Predicted Opening Price for Astria Therapeutics, Inc. of Monday, April 29, 2024
Fair opening price April 29, 2024 | Current price |
---|---|
$9.14 ( 1.59%) | $9.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ATXS
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 9.63 | 7.04 % | |
R2 | 9.45 | 4.96 % | ||
R1 | 9.33 | 3.67 % | ||
Current price: | 9.00 | |||
Support | S1 | 8.96 | -0.487 % | |
S2 | 8.84 | -1.77 % | ||
S3 | 8.65 | -3.85 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 9.80 | 8.89 % | |
R2 | 9.75 | 8.33 % | ||
R1 | 9.17 | 1.89 % | ||
Current price | 9.00 | |||
Support | S1 | 0 | . | |
S2 | 0 | . | ||
S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Astria Therapeutics, Inc. Stock.